COMPANY
Making medicine from the building blocks of life
WHO WE ARE
A pharmaceutical company focused on one substance
Founded in Hong Kong in July 2026, Synthena is a pharmaceutical company focused on one substance: PDRN. Our aim is to turn PDRN into medicines made without animal-derived sources, produced within a defined fragment-length range and studied across five fields of human biology.
THE SOURCE
We chose the harder source on purpose.
We make our PDRN from plant cells and from microbes. They are harder to open than animal tissue, and they let us control the starting material from the first step.
TOWARD MEDICINE
Advancing into five programmes
We are evaluating the same defined PDRN in each of the five fields. They are the circulation, the skin, the joints, the gut and the nervous system.
Science